TURKEL CATHERINE C. 4
4 · Lexaria Bioscience Corp. · Filed May 10, 2024
Insider Transaction Report
Form 4
TURKEL CATHERINE C.
Director
Transactions
- Award
Stock Options
2024-04-26+5,000→ 15,000 totalExercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (5,000 underlying)
Holdings
- 5,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (1,600 underlying) - 1,500
common shares
- 3,400
Stock Options
Exercise: $3.04From: 2022-09-02Exp: 2027-09-02→ Common Shares (3,400 underlying) - 10,000
Stock Options
Exercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying)